Leerink Partnrs Lowers Earnings Estimates for agilon health

agilon health, inc. (NYSE:AGL) – Stock analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for agilon health in a research note issued to investors on Monday, November 11th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $0.05 for the quarter, down from their prior estimate of $0.08. The consensus estimate for agilon health’s current full-year earnings is ($0.32) per share.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 46.06% and a negative net margin of 6.88%. During the same quarter last year, the business posted ($0.06) earnings per share.

Several other analysts have also issued reports on AGL. Barclays lowered their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Stifel Nicolaus decreased their price objective on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday. Citigroup reiterated a “sell” rating and set a $2.50 price objective (down from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. Finally, Evercore ISI decreased their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 8th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, agilon health currently has an average rating of “Hold” and a consensus price target of $7.03.

agilon health Stock Performance

Shares of AGL opened at $1.87 on Wednesday. The firm has a market cap of $767.41 million, a PE ratio of -1.98 and a beta of 0.60. The stock’s fifty day moving average price is $3.18 and its two-hundred day moving average price is $4.93. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. agilon health has a 1 year low of $1.80 and a 1 year high of $13.76.

Insider Transactions at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after acquiring an additional 371,537 shares during the period. AQR Capital Management LLC raised its position in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC raised its position in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Capital International Investors raised its position in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares during the last quarter. Finally, Simplicity Wealth LLC raised its position in agilon health by 145.1% during the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after purchasing an additional 15,515 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.